Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Associated With Iodinated Contrast Media: A Case Report with Fatal Outcome and Literature Review
Main Article Content
Abstract
An adverse drug reaction (ADR) is defined by the World Health Organization (WHO) as any harmful and undesired response to a drug that occurs at doses normally used in humans for prophylaxis, diagnosis, treatment of a disease, or to modify a physiological function (1). Cutaneous adverse drug reactions (CADRs), or pharmacodermias, are a type of ADR that manifest in the skin, mucous membranes, and/or appendages (1). Their broad clinical presentation can pose a diagnostic challenge. Currently, with the constant development of new diagnostic and therapeutic options, exposure to various types of medications has increased, necessitating a high index of suspicion and the ability to detect any manifestation of a potential ADR. Furthermore, there is limited information on ADRs related to iodinated contrast media, as non-immediate hypersensitivity reactions are estimated to occur in only 0.5% to 3% of exposed patients, with even fewer reported cases of severe, potentially life-threatening reactions. We present the case of a patient with chronic exposure to medications for managing comorbidities, who developed a drug reaction with eosinophilia and systemic symptoms (DRESS) following exposure to iodinated contrast media as part of his diagnostic and therapeutic workup, ultimately leading to his death.
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Farmacodermias -- Manual Digital de Dermatología. (n.d.). Edu.ar.Retrieved February 27, 2025, from
II. Gómez-Cerdas M, Corrales-Morales T, Ugalde-Jimenez O. DRESS syndrome: diagnostic and therapeutic approach. Revista Médica
Sinergia (201). Vol 4 Num 6: 60-72.
doi:https://doi.org/10.31434/rms.v4i6.244
III. Alonso-Martínez B, Cantón-de-Seoane J, Lois-Martínez N, del-Valle-Loarte P. Síndrome de DRESS secundario a suplemento yodado. Rev Esp Casos Clin Med Intern (RECCMI). 2021 (dic); 6(3):
-21. doi: 10.32818/reccmi.a6n3a7.
IV. Calle A, Aguirre N, Ardila J, Cardona-Villa R. DRESS syndrome: A literature review and treatment algorithm. Allergy Organization Journal (2023). doi: http://doi.org/10.1016/j.waojou.2022.100673
V. Echeverría M, Torre A, Riganti J, Mazzuoccolo L. Drug reaction with eosinophilia and systemic symptoms (DRESS). Dermatología Argentina.
Vol No. 28 Enero-Marzo 2022: 03-13
VI. Zambrano Ibarra G, Noguerado Mellado B, Tornero Molina P, Cuevas Bravo C, Rojas Pérez-Esquerra P. DRESS syndrome due to iodinated contrast media. A case report. Allergy Asthma Clin Immunol. 2023 Feb 27;19(1):16. doi: 10.1186/s13223-023-00774-7. PMID: 36849962; PMCID:PMC9972718.
VII. Garrido F, Rivera S, Presenti J, Riquelme C, Huete A. Intravascular contrast media in computed tomography and magnetic resonance imaging: what the clinician needs to know (2020). Revista de
Ciencias Médicas. Vol. 45 No. 1.